Sanofi Cash Flow-to-Debt Ratio
Sanofi cash flow-to-debt ratio. Sanofi (SNYN) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of MX$2.96 Billion could theoretically repay 0% of its total liabilities (MX$59.49 Billion) in one year. Check SNYN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sanofi (2013–2025)
Cash flow-to-debt ratio of Sanofi from 2013 to 2025. Historical debt coverage capacity for Sanofi across 13 annual periods. Check how high is Sanofi's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sanofi Cash Flow-to-Debt Ratio by Year (2013–2025)
Sanofi cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Sanofi. For the full cash flow conversion analysis, see SNYN cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (MXN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | MX$10.75 Billion | MX$55.09 Billion | ▲ +18.0% |
| 2024 | 0.17x | MX$9.08 Billion | MX$54.94 Billion | ▼ -16.0% |
| 2023 | 0.20x | MX$10.26 Billion | MX$52.11 Billion | ▼ -4.5% |
| 2022 | 0.21x | MX$10.53 Billion | MX$51.07 Billion | ▲ +0.3% |
| 2021 | 0.21x | MX$10.52 Billion | MX$51.21 Billion | ▲ +42.3% |
| 2020 | 0.14x | MX$7.42 Billion | MX$51.38 Billion | ▲ +0.4% |
| 2019 | 0.14x | MX$7.71 Billion | MX$53.63 Billion | ▲ +35.8% |
| 2018 | 0.11x | MX$5.55 Billion | MX$52.37 Billion | ▼ -40.3% |
| 2017 | 0.18x | MX$7.38 Billion | MX$41.57 Billion | ▲ +6.3% |
| 2016 | 0.17x | MX$7.84 Billion | MX$46.95 Billion | ▼ -17.4% |
| 2015 | 0.20x | MX$8.92 Billion | MX$44.11 Billion | ▲ +8.1% |
| 2014 | 0.19x | MX$7.69 Billion | MX$41.12 Billion | ▲ +4.9% |
| 2013 | 0.18x | MX$6.95 Billion | MX$39.02 Billion | — |